Octagon Capital Advisors LP Quant / Systematic

CIK: 0001839435 · Show all filings

Period: Q2 2021 (← Previous) (Next →)

Filing Date: Aug 16, 2021

Total Value ($000): $482,813 (100.0% shares, 0.0% debt)

Holdings (34)

APLS APELLIS PHARMACEUTICALS INC 16.4%
Value ($000) $79,396 Shares 1,256,265 Est. Cost $47.54 Unrealized +8.5%
NBP I MAB 16.4%
Value ($000) $79,178 Shares 943,156 Est. Cost $63.37 Unrealized
CURIS INC 6.0%
Value ($000) $28,912 Shares 3,582,629 Est. Cost $8.14 Unrealized
BBIO BRIDGEBIO PHARMA INC 4.8%
Value ($000) $23,221 Shares 380,928 Est. Cost $57.11 Unrealized 0.0%
RCUS ARCUS BIOSCIENCES INC 4.3%
Value ($000) $20,874 Shares 760,164 Est. Cost $27.66 Unrealized +3.3%
FDMT 4D MOLECULAR THERAPEUTICS IN 4.1%
Value ($000) $20,017 Shares 831,267 Est. Cost $35.47 Unrealized -13.7%
ZLAB ZAI LAB LTD 4.0%
Value ($000) $19,351 Shares 109,335 Est. Cost $176.99 Unrealized
CLDX CELLDEX THERAPEUTICS INC NEW 3.9%
Value ($000) $18,773 Shares 561,398 Est. Cost $18.00 Unrealized +52.5%
VERA VERA THERAPEUTICS INC 3.1%
Value ($000) $15,008 Shares 1,132,671 Est. Cost $15.54 Unrealized 0.0%
ACCELERON PHARMA INC 2.9%
Value ($000) $14,100 Shares 112,363 Est. Cost $127.94 Unrealized
ARVN ARVINAS INC 2.8%
Value ($000) $13,745 Shares 178,500 Est. Cost $34.48 Unrealized +101.3%
DYN DYNE THERAPEUTICS INC 2.5%
Value ($000) $12,280 Shares 583,649 Est. Cost $19.71 Unrealized -4.6%
IPSC CENTURY THERAPEUTICS INC 2.5%
Value ($000) $11,839 Shares 403,523 Est. Cost $25.37 Unrealized 0.0%
GOSS GOSSAMER BIO INC 2.4%
Value ($000) $11,475 Shares 1,413,138 Est. Cost $9.85 Unrealized -12.0%
RNAM AVIDITY BIOSCIENCES INC 2.3%
Value ($000) $11,036 Shares 446,641 Est. Cost $28.99 Unrealized -19.7%
STOK STOKE THERAPEUTICS INC 2.1%
Value ($000) $9,991 Shares 296,822 Est. Cost $35.35 Unrealized 0.0%
AMBRX BIOPHARMA INC 1.8%
Value ($000) $8,820 Shares 450,000 Est. Cost $19.60 Unrealized
PMVP PMV PHARMACEUTICALS INC 1.8%
Value ($000) $8,540 Shares 250,000 Est. Cost $39.23 Unrealized -14.9%
CONNECT BIOPHARMA HLDGS LTD 1.5%
Value ($000) $7,294 Shares 373,492 Est. Cost $18.50 Unrealized
TSHA TAYSHA GENE THERAPIES INC 1.4%
Value ($000) $6,793 Shares 320,440 Est. Cost $21.54 Unrealized +7.0%
CRDF CARDIFF ONCOLOGY INC 1.4%
Value ($000) $6,535 Shares 982,753 Est. Cost $14.50 Unrealized -41.5%
IKENA ONCOLOGY INC 1.2%
Value ($000) $5,616 Shares 400,000 Est. Cost $28.25 Unrealized
GLUE MONTE ROSA THERAPEUTICS INC 1.1%
Value ($000) $5,404 Shares 238,045 Est. Cost $20.37 Unrealized 0.0%
DSGN DESIGN THERAPEUTICS INC 1.0%
Value ($000) $4,973 Shares 250,000 Est. Cost $31.14 Unrealized -19.0%
PROMETHEUS BIOSCIENCES INC 1.0%
Value ($000) $4,912 Shares 200,000 Est. Cost $18.26 Unrealized
KYMR KYMERA THERAPEUTICS INC 1.0%
Value ($000) $4,850 Shares 100,000 Est. Cost $43.41 Unrealized 0.0%
MERUS N V 0.9%
Value ($000) $4,360 Shares 206,927 Est. Cost $20.90 Unrealized
IVERIC BIO INC 0.9%
Value ($000) $4,291 Shares 680,036 Est. Cost $6.91 Unrealized
MLTX HELIX ACQUISITION CORP 0.9%
Value ($000) $4,132 Shares 400,000 Est. Cost $11.37 Unrealized
RVMD REVOLUTION MEDICINES INC 0.8%
Value ($000) $4,004 Shares 126,136 Est. Cost $39.54 Unrealized -11.7%
NGM BIOPHARMACEUTICALS INC 0.8%
Value ($000) $3,944 Shares 200,000 Est. Cost $29.53 Unrealized
KRONOS BIO INC 0.7%
Value ($000) $3,501 Shares 146,173 Est. Cost $29.87 Unrealized
JIYA ACQUISITION CORP 0.6%
Value ($000) $2,982 Shares 300,000 Est. Cost $10.30 Unrealized
EWTX EDGEWISE THERAPEUTICS INC 0.6%
Value ($000) $2,666 Shares 125,000 Est. Cost $32.43 Unrealized -15.7%